Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr 26;117(8):5226-5333.
doi: 10.1021/acs.chemrev.6b00478. Epub 2016 Dec 12.

Oxidative Cyclization in Natural Product Biosynthesis

Affiliations
Review

Oxidative Cyclization in Natural Product Biosynthesis

Man-Cheng Tang et al. Chem Rev. .

Abstract

Oxidative cyclizations are important transformations that occur widely during natural product biosynthesis. The transformations from acyclic precursors to cyclized products can afford morphed scaffolds, structural rigidity, and biological activities. Some of the most dramatic structural alterations in natural product biosynthesis occur through oxidative cyclization. In this Review, we examine the different strategies used by nature to create new intra(inter)molecular bonds via redox chemistry. This Review will cover both oxidation- and reduction-enabled cyclization mechanisms, with an emphasis on the former. Radical cyclizations catalyzed by P450, nonheme iron, α-KG-dependent oxygenases, and radical SAM enzymes are discussed to illustrate the use of molecular oxygen and S-adenosylmethionine to forge new bonds at unactivated sites via one-electron manifolds. Nonradical cyclizations catalyzed by flavin-dependent monooxygenases and NAD(P)H-dependent reductases are covered to show the use of two-electron manifolds in initiating cyclization reactions. The oxidative installations of epoxides and halogens into acyclic scaffolds to drive subsequent cyclizations are separately discussed as examples of "disappearing" reactive handles. Last, oxidative rearrangement of rings systems, including contractions and expansions, will be covered.

PubMed Disclaimer

Figures

Scheme 1
Scheme 1
Catalytic Cycle of Cytochrome P450
Scheme 2
Scheme 2
Catalytic Cycle of Nonheme Iron α-KG-Dependent Oxygenase
Scheme 3
Scheme 3
Catalytic Cycle of Radical SAM Enzyme
Scheme 4
Scheme 4
Catalytic Cycle of Copper-Dependent Tyrosinase
Scheme 5
Scheme 5
Catalytic Cycle of Flavin-Dependent Monooxygenase
Scheme 6
Scheme 6
NAD(P)H-Dependent Reductases and Dehydrogenases
Scheme 7
Scheme 7
Models of Radical Cyclization in Natural Product Biosynthesis
Scheme 8
Scheme 8
P450-Catalyzed Phenol Coupling Reactions in Glycopeptide Biosynthesis
Scheme 9
Scheme 9
Mechanistic Proposal of C-C and C-O Phenol Coupling Catalyzed by P450
Scheme 10
Scheme 10
Oxidative Coupling in Indolocarbazole Biosynthesis
Scheme 11
Scheme 11
Mechanistic Proposal for Chromopyrrolic Acid Formation
Scheme 12
Scheme 12
Proposed Catalytic Mechanism of Indole Coupling in Indolocarbazole Biosynthesis
Scheme 13
Scheme 13
Alternative Proposal for the Mechanism of StaP
Scheme 14
Scheme 14
Proposed Catalytic Mechanism for the Last C-N Coupling Step in Staurosporine Biosynthesis
Scheme 15
Scheme 15
Formation of the Communesin Core by the P450 CnsC
Scheme 16
Scheme 16
Biomimetic Synthesis of Communesin K by Movassaghi
Scheme 17
Scheme 17
Possible Mechanisms of CYP121 catalyzed C-C coupling in Mycocyclosin Pathway
Scheme 18
Scheme 18
Possible Mechanisms of P450-catalyzed C-C Coupling in Herquline Pathway
Scheme 19
Scheme 19
Proposed Pathway for C-C Coupling in Usnic Acid
Scheme 20
Scheme 20
Computationally Predicted Oxidative Cyclization Mechanism of VrtK
Scheme 21
Scheme 21
Proposed Radical Mediated Cyclization in Brefeldin A Biosynthesis
Scheme 22
Scheme 22
P450 Catalyzed C-C Coupling in Salutaridine and Magnoflorine Biosynthesis
Scheme 23
Scheme 23
P450 Catalyzed Phenol Coupling in Amaryllidaceae Alkaloid Biosynthesis
Scheme 24
Scheme 24
Diradical Combination in (+)-Pinoresinol Biosynthesis
Scheme 25
Scheme 25
Possible Mechanisms of GsfF catalyzed C-O Coupling in Griseofulvin Biosynthesis
Scheme 26
Scheme 26
Multi-copper Protein Catalyzed C-O Coupling to from Grisan-Containing Compounds
Scheme 27
Scheme 27
Heterodimeric Radical Coupling in Tubocurarine Biosynthesis
Scheme 28
Scheme 28
Proposed Mechanisms of P450-catalyzed Formation of Tetrahydrofuran in Aureothin
Scheme 29
Scheme 29
Proposed mechanisms of P450 Catalyzed Oxidative Cyclization in Penitrem D Pathway
Scheme 30
Scheme 30
Proposed Oxidative Cyclization Mechanisms in Pyrrocidine Biosynthesis
Scheme 31
Scheme 31
Proposed Mechanism of P450 Catalyzed Phenoxy Radical Addition in Salinamide Pathway
Scheme 32
Scheme 32
Mechanism of Reactions Catalyzed by Allene Oxide Synthase (CYP74A)
Scheme 33
Scheme 33
P450 Catalyzed Formation of Methylenedioxy Bridge in Natural Products
Scheme 34
Scheme 34
Possible Mechanisms of P450 Catalyzed C-N Coupling in Fumitremorgin C Pathway
Scheme 35
Scheme 35
Possible Mechanisms of P450-Catalyzed C-N Coupling in Indolactam Pathway
Scheme 36
Scheme 36
Possible Mechanisms of P450 Catalyzed C-S Coupling in Griseoviridin Pathway
Scheme 37
Scheme 37
Possible Mechansims of the EasH Catalyzed Cyclopropane Formation in Cycloclavine
Scheme 38
Scheme 38
Mechanism of SnoK Catalyzed C-C Coupling in Nogalamycin Biosynthesis
Scheme 39
Scheme 39
Biosynthetic Pathway of (−)-4-Desmethylepipodophyllotoxin in Mayapple
Scheme 40
Scheme 40
cpEasH Catalyzed C-O coupling in Dihydroergotamine Biosynthesis
Scheme 41
Scheme 41
Oxidative Cyclization in Orthosomycin Biosynthesis
Scheme 42
Scheme 42
Mechanism of Oxidative Cyclization During Clavaminic Acid Formation
Scheme 43
Scheme 43
Proposed Mechanism of Epoxide Formation in Scopolamine by Hyoscyamine 6β-Hydroxylase
Scheme 44
Scheme 44
Proposed Mechanism of FtmOx1 Catalyzed Endoperoxide Formation
Scheme 45
Scheme 45
Mechanism of C-N Coupling in Capreomycidine Formation
Scheme 46
Scheme 46
Mechanisms of Methylproline Formation in NRP Natural Products
Scheme 47
Scheme 47
Biosynthesis of Fosfomycin and Proposed Mechanism of HppE
Scheme 48
Scheme 48
Mechanism of Isopenicillin N Synthase
Scheme 49
Scheme 49
Proposed Catalytic Cycle of Rieske Oxygenases in Prodiginine Biosynthesis
Scheme 50
Scheme 50
Proposed Mechanism of C-C coupling in Streptide Biosynthesis
Scheme 51
Scheme 51
Proposed mechanism of C-C Coupling in Menaquinone Biosynthesis
Scheme 52
Scheme 52
Proposed Mechanism of Radical-SAM Enzyme Catalyzed Cyclopropanation in Jawsamycin
Scheme 53
Scheme 53
Mechanism of C-S Coupling Steps in Biotin Biosynthesis
Scheme 54
Scheme 54
Proposed Mechanisms of C-S Coupling Steps in Subtilosin Biosynthesis
Scheme 55
Scheme 55
Models of Nonradical Cyclization in Natural Product Biosynthesis
Scheme 56
Scheme 56
Reduction-Enabled Cyclization in Nostocyclopeptide A2 Biosynthesis
Scheme 57
Scheme 57
Pictet-Spengler Reactions in Saframycin A Biosynthesis
Scheme 58
Scheme 58
Reduction-Enabled Hetero Diel-Alder Cyclization in Leporin Biosynthesis
Scheme 59
Scheme 59
Hydride-Mediated Cyclization in Ikarugamycin Biosynthesis
Scheme 60
Scheme 60
Reductive Cyclization of Iridoid by Iridoid Synthase in Plants
Scheme 61
Scheme 61
The Reaction Catalyzed by Berberine Bridge Enzyme in S-Scoulerine Biosynthesis
Scheme 62
Scheme 62
Proposed Role of BBE in Fumoisoquins Biosynthesis
Scheme 63
Scheme 63
Proposed Mechanism of Tetrahydrocannabinol Biosynthesis
Scheme 64
Scheme 64
Desaturative Macrocyclization in Lankacidin Biosynthesis
Scheme 65
Scheme 65
Desaturative Cyclization in Cyclopiazonic acid Biosynthesis
Scheme 66
Scheme 66
Mechanism of Chlorizidine A Cyclization
Scheme 67
Scheme 67
Selected Natural Products that Contain Oxazole and Thiazole Rings
Scheme 68
Scheme 68
Mechanisms of Oxazole and Thiozole Formation
Scheme 69
Scheme 69
Disulfide Bond Formation from Dithiols in Natural Products Biosynthesis
Scheme 70
Scheme 70
Examples of Disulfide Variants in Leinamycin and Echinomycin
Scheme 71
Scheme 71
Formation of L-Pipecolic Acid in Natural Products
Scheme 72
Scheme 72
Cyclization of Chanoclavine-I to D-Lysergic Acid
Scheme 73
Scheme 73
Oxidative Formation of 6,6-Spiroacetal as Shown in Reveromycin
Scheme 74
Scheme 74
Oxidative Scaffold Maturation in Fungal Indole Alkaloid Biosynthesis
Scheme 75
Scheme 75
Transient Oxidation of Catechols to Set up Cyclization
Scheme 76
Scheme 76
Oxidative Formation of Phenalenone
Scheme 77
Scheme 77
Flavoenzyme Catalyzed Favorskii Rearrangement in Enterocin Biosynthesis
Scheme 78
Scheme 78
Cyclization of L-Ornithine to Piperazic Acid in NRP Natural Products
Scheme 79
Scheme 79
Proposed Formation of Furanone Scaffold in Aurafuron A Biosynthesis
Scheme 80
Scheme 80
Proposed Diels-Alder Reaction in Sordarin Biosynthesis
Scheme 81
Scheme 81
Oxidation Mediated [4+2] Cyclizations in Solanapyrone Biosynthesis
Scheme 82
Scheme 82
On-Assembly Line Diels-Alder Reaction During Lovastatin Biosynthesis
Scheme 83
Scheme 83
Cyclization Steps in Spinosyn A Biosynthesis
Scheme 84
Scheme 84
[4+2] Cyclization in Formation of 5,6-Spirocycle in Abyssomicin C
Scheme 85
Scheme 85
[4+2] Cyclizations in Formation of cis-Decalin and 5,6-Spirocycle in Pyrroindomycin B
Scheme 86
Scheme 86
Models of Cyclization via Epoxidation in Natural Product Biosynthesis
Scheme 87
Scheme 87
P450 and Flavoenzyme Catalyzed Formation of Epoxides
Scheme 88
Scheme 88
Cyclic Polyethers formation via Epoxide Intermediates
Scheme 89
Scheme 89
Mechanism of Polyether Formation in Monensin Biosynthesis
Scheme 90
Scheme 90
Mechanism of Polyether Formation in Nanchangmycin Biosynthesis
Scheme 91
Scheme 91
Proposed mechanism of Polyether Formation in Heronapyrrole Biosynthesis
Scheme 92
Scheme 92
Cyclic Ethers formation via Epoxide Intermediates in Solamin and Aurovertin
Scheme 93
Scheme 93
Triterpene Cyclization via Epoxide and Cation Intermediates
Scheme 94
Scheme 94
Engineering of Squalene-Hopene Cyclase as a Protonase
Scheme 95
Scheme 95
Alternative Triterpene Cyclization in Yardenone and Abudinol Biosynthesis
Scheme 96
Scheme 96
Epoxide Mediated Cyclization in Xiamycin Biosynthesis
Scheme 97
Scheme 97
Epoxide Mediated Cyclization in Paxilline and Emindoles Biosynthesis
Scheme 98
Scheme 98
Epoxide Mediated Cyclization in Anominine, Aflavinine and Tubingensin Biosynthesis
Scheme 99
Scheme 99
Epoxide Mediated Cyclization in Pyripyopene Biosynthesis
Scheme 100
Scheme 100
Biosynthetic Pathway of Fungal Meroterpenoids
Scheme 101
Scheme 101
Enzyme-Catalyzed Cationic Epoxide Rearrangements in Quinolone Alkaloid Biosynthesis
Scheme 102
Scheme 102
Proposed Cyclization Mechanism during Aurachin A Biosynthesis
Scheme 103
Scheme 103
Oxetane Formation via an Epoxide Intermediate During Paclitaxel Maturation
Scheme 104
Scheme 104
Proposed Epoxide Intermediates in Acetylaranotin and Gliotoxin Biosynthesis
Scheme 105
Scheme 105
Indole Epoxidation as a Key Step in Fungal Indole Alkaloid Biosynthesis
Scheme 106
Scheme 106
Indole Epoxidation in Notoamide Biosynthesis
Scheme 107
Scheme 107
Indole Epoxidation Sets Up Spirocycle Formation in Spirotryprostatin
Scheme 108
Scheme 108
Indole Epoxidation Mediated Carbazole Formation in Xiamycin Biosynthesis
Scheme 109
Scheme 109
Indole Epoxidation Mediated Cyclization in Plant Metabolite Biosynthesis
Scheme 110
Scheme 110
Epoxidation Mediated Cyclization in Heronamides Biosynthesis
Scheme 111
Scheme 111
Epoxidation Mediated Oxo-Spiro Ring Formation in Pseurotin A Biosynthesis
Scheme 112
Scheme 112
Cyclopentenone Formation in Jasmonic acid and Clavulone I Biosynthesis
Scheme 113
Scheme 113
Models of Cyclization via Halogenation in Natural Product Biosynthesis
Scheme 114
Scheme 114
Catalytic Cycles of Vanadium Haloperoxidases and α-KG Dependent Halogenase
Scheme 115
Scheme 115
VHPO Catalyzed Formation of Merochlorins
Scheme 116
Scheme 116
Halogenation as a Key Step in SF2415B3 Biosynthesis
Scheme 117
Scheme 117
Bromination Triggered Cyclization in Laurencin, Laureatin and Snyderol Biosynthesis
Scheme 118
Scheme 118
Chlorination Mediated Cyclopropane Formation During Curacin A Biosynthesis
Scheme 119
Scheme 119
Chlorination Mediated Cyclopropane Formation During Coronatine Biosynthesis
Scheme 120
Scheme 120
Chlorination Mediated Cyclopropane Formation During Kutzneride Biosynthesis
Scheme 121
Scheme 121
Oxidative Ring Contraction to Form Viridicatin
Scheme 122
Scheme 122
P450 Catalyzed Ring Contraction in Gibberellic Acid 12 Biosynthesis
Scheme 123
Scheme 123
Dioxabicyclo[3.2.1]octane Formation in Saliniketals Biosynthesis
Scheme 124
Scheme 124
Oxidative Ring Contraction in Griseorhodin A Biosynthesis
Scheme 125
Scheme 125
Oxidative Ring Contraction in Spirotryprostatin G Biosynthesis
Scheme 126
Scheme 126
Cyclopentenone Ring Formation in Xenovulene A Biosynthesis
Scheme 127
Scheme 127
Baeyer-Villiger Oxidation in Pentalenolactone Biosynthesis
Scheme 128
Scheme 128
Baeyer-Villiger Oxidation in Preaustinoid A1 Biosynthesis
Scheme 129
Scheme 129
Baeyer-Villiger Oxidation in Cytochalasin Biosynthesis
Scheme 130
Scheme 130
P450 Catalyzed Baeyer-Villiger Ring Expansion in Brassinosteroid Biosynthesis
Scheme 131
Scheme 131
Oxidative Ring Expansion in Desacetoxycephalosporin C Biosynthesis
Scheme 132
Scheme 132
Tropolone Ring Formation in Stipitatic Acid Biosynthesis
Scheme 133
Scheme 133
Oxidative Ring Expansion in Acetylaranotin Biosynthesis
Scheme 134
Scheme 134
P450 Catalyzed Tetramic Acid to Pyridone in Aspyridone Biosynthesis
Scheme 135
Scheme 135
P450 Catalyzed Ring Expansion in Penitrem A Biosynthesis
Scheme 136
Scheme 136
Ring Modifications in Anditomin Biosynthesis
Scheme 137
Scheme 137
Proposed Mechanisms of Carbon Scaffold Rearrangement during Fumagillin Biosynthesis
Scheme 138
Scheme 138
Tri-aminal Formation during Meleagrin Biosynthesis
Scheme 139
Scheme 139
Xanthone Formation via a Cryptic Demethoxylation in Xantholipin Biosynthesis
Scheme 140
Scheme 140
Angular Polyaromatic Framework Formation in Chartreusin Biosynthesis
Scheme 141
Scheme 141
Proposed pathways of Oxazolidinone Formation in Jadomycin Biosynthesis
Scheme 142
Scheme 142
Anthracycline to Angucycline Rearrangement in PD116198 Biosynthesis
Scheme 143
Scheme 143
Oxidative Ring Arrangements During Aflatoxin Maturation
Scheme 144
Scheme 144
Oxidative Rearrangements in Betalamic Acid Biosynthesis

References

    1. Newman DJ, Cragg GM. Natural Products as Sources of New Drugs from 1981 to 2014. J Nat Prod. 2016;79(3):629–661. - PubMed
    1. Cragg GM, Newman DJ. Natural Products: A Continuing Source of Novel Drug Leads. Biochim Biophys Acta. 2013;1830(6):3670–3695. - PMC - PubMed
    1. Mishra BB, Tiwari VK. Natural Products: An Evolving Role in Future Drug Discovery. Eur J Med Chem. 2011;46(10):4769–4807. - PubMed
    1. Walsh CT. A Chemocentric View of the Natural Product Inventory. Nat Chem Biol. 2015;11(9):620–624. - PubMed
    1. Walsh CT, Fischbach MA. Natural Products Version 2.0: Connecting Genes to Molecules. J Am Chem Soc. 2010;132(8):2469–2493. - PMC - PubMed